Literature DB >> 14670915

HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype.

Sandrine Jacolot1, Gerald Le Gac, Virginie Scotet, Isabelle Quere, Catherine Mura, Claude Ferec.   

Abstract

Hereditary hemochromatosis is a genetically heterogeneous disease of iron metabolism. The most common form of the disorder is an adult-onset form that has mainly been associated with the HFE pC282Y/pC282Y genotype. The phenotypic expression of this genotype is very heterogeneous and could be modulated by both environmental factors and modifier genes. The non-HFE hereditary hemochromatosis forms include a juvenile onset form associated with mutations in HAMP. From a cohort of 392 C282Y homozygous patients, we found 5 carriers of an additional HAMP mutation at the heterozygous state (pR59G, pG71D, or pR56X). We found that iron indices of these 5 patients were among the most elevated of the cohort. Moreover, we specified that the HAMP mutations were not detected in 300 control subjects. These results revealed that mutations in HAMP might increase the phenotypic expression of the pC282Y/pC282Y genotype. From a cohort of 31 patients with at least one chromosome lacking an HFE mutation, we further identified 4 males carrying a heterozygous HAMP mutation (pR59G or pG71D). Based on a digenic model of inheritance, these data suggest that the association of heterozygous mutations in the HFE and HAMP genes could lead, at least in some cases, to an adult-onset form of primary iron overload.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670915     DOI: 10.1182/blood-2003-10-3366

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  Phenotypic expression of hereditary hemochromatosis: what have we learned from the population studies?

Authors:  Eng K Gan; Oyekoya T Ayonrinde; Debbie Trinder; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2010-02

2.  CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.

Authors:  Sara Pelucchi; Raffaella Mariani; Stefano Calza; Anna Ludovica Fracanzani; Giulia Litta Modignani; Francesca Bertola; Fabiana Busti; Paola Trombini; Mirella Fraquelli; Gian Luca Forni; Domenico Girelli; Silvia Fargion; Claudia Specchia; Alberto Piperno
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

3.  New HJV mutation in a patient with hyperferritinemia and H63D homozygosity for the HFE gene.

Authors:  Carles de Diego; Sonsoles Opazo; Angel Sánchez-Castaño; Pedro Martínez-Castro
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

Review 4.  Genetic epidemiology of primary sclerosing cholangitis.

Authors:  Tom-H Karlsen; Erik Schrumpf; Kirsten-Muri Boberg
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

5.  Commentary to: "Post-translational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin," by Erika Valore and Tomas Ganz.

Authors:  Pauline Lee
Journal:  Blood Cells Mol Dis       Date:  2007-10-01       Impact factor: 3.039

6.  Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.

Authors:  J Vázquez-Mellado; V Alvarado-Romano; R Burgos-Vargas; A L Jiménez-Vaca; G Pozo-Molina; S A Cuevas-Covarrubias
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

Review 7.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

8.  The global burden of iron overload.

Authors:  Marnie J Wood; Richard Skoien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2009-07-29       Impact factor: 6.047

9.  Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice.

Authors:  Constance Delaby; Vincent Oustric; Caroline Schmitt; Francoise Muzeau; Anne-Marie Robreau; Philippe Letteron; Eric Couchi; Angel Yu; Saïd Lyoumi; Jean-Charles Deybach; Herve Puy; Zoubida Karim; Carole Beaumont; Bernard Grandchamp; Peter Demant; Laurent Gouya
Journal:  Mamm Genome       Date:  2013-12       Impact factor: 2.957

10.  Clinical penetrance of C282Y homozygous HFE haemochromatosis.

Authors:  Enrico Rossi; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.